Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Ivermectin Side Effects and Management

Common Side Effects

  • Ivermectin is generally well-tolerated at approved doses for parasitic infections, with the most common side effects being dizziness, nausea, fever, headache, muscle or joint pain, and skin reactions, while serious adverse events are rare 1
  • When used at standard dosing (200-250 μg/kg) for approved parasitic infections, patients typically experience mild and transient symptoms: dizziness, nausea, fever, headache, and muscle/joint pain are the most frequently reported side effects 1, 2

Special Populations at Higher Risk

  • Patients with severe liver disease may be at increased risk for toxicity, as safety in this population is not well-established 1, 2

Management of Adverse Effects

  • Topical reactions can be relieved with topical corticosteroids and oral antihistamines 1
  • Severe reactions in onchocerciasis may require pretreatment with corticosteroids in high-risk patients 1

Important Dosing Considerations

  • Take on an empty stomach with water, as bioavailability increases 2.5-fold with high-fat food 1
  • Standard dosing for parasitic infections is 200-250 μg/kg 2

COVID-19 Context

  • Moderate certainty evidence suggests ivermectin may increase the risk of serious adverse events in hospitalized patients (RR 3.10, 95% CI 0.54-17.89), though the evidence remains imprecise 3
  • The World Health Organization strongly recommends against ivermectin for COVID-19 outside clinical trials, noting it diverts resources from proven therapies 4

REFERENCES

1

Ivermectin Side Effects and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Ivermectin Toxicity Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025